Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Natalie R. Streeter
Observed names:
Natalie R. Streeter,
Natalie Streeter
Institutions:
The University of Kansas Cancer Center,
University of Kansas Medical Center
Observed institutions:
University of Kansas,
The University of Kansas Cancer Center,
University of Kansas Medical Center,
University of Pittsburgh Medical Center
ORCID:
0000-0003-3309-1992
Observed ORCID:
0000-0003-3309-1992
OpenAlex ID:
A5006616356
A phase 2 trial of regorafenib as a single agent in patients with chemotherapy‐refractory, advanced, and metastatic biliary tract adenocarcinoma
2018
·
Weijing Sun
, Anuj Patel
, et al.
·
Cancer
·
127
Phase 2 study of pembrolizumab in combination with azacitidine in subjects with metastatic colorectal cancer.
2017
·
James J. Lee
, Weijing Sun
, et al.
·
Journal of Clinical Oncology
·
32
Evaluation of the Durability of the Immune Humoral Response to COVID-19 Vaccines in Patients With Cancer Undergoing Treatment or Who Received a Stem Cell Transplant
2022
·
Qamar J. Khan
, Cory R. Bivona
, et al.
·
JAMA Oncology
·
24
PDF
A phase II study of perioperative pembrolizumab plus mFOLFOX in patients with potentially resectable esophagus, gastroesophageal junction ( GEJ ), and stomach adenocarcinoma
2023
·
Weijing Sun
, Nirmal Veeramachaneni
, et al.
·
Cancer Medicine
·
23
PDF
A phase II study of perioperative mFOLFOX plus pembrolizumab combination in patients with potentially resectable adenocarcinoma of the esophageal, gastroesophageal junction (GEJ) and stomach.
2022
·
Weijing Sun
, Anwaar Saeed
, et al.
·
Journal of Clinical Oncology
·
6
Prospective longitudinal study of kinetics of humoral response to one, two, or three doses of SARS-CoV-2 vaccine in hematopoietic cell transplant recipients
2022
·
Qamar J. Khan
, Cory R. Bivona
, et al.
·
Bone Marrow Transplantation
·
6
PDF
A phase 2 trial of regorafenib as a single agent in patients with chemotherapy refractory advanced and metastatic biliary adenocarcinoma/cholangiocarcinoma.
2017
·
Weijing Sun
, Daniel Paul Normolle
, et al.
·
Journal of Clinical Oncology
·
6
Bolstering the complex study start-up process at NCI cancer centers using technology
2022
·
Dinesh Pal Mudaranthakam
, Sam Pepper
, et al.
·
Contemporary Clinical Trials Communications
·
2
PDF
Evaluating the impact of delayed study startup on accrual in cancer studies
2025
·
Isuru Ratnayake
, Anh-Tuan Do
, et al.
·
Contemporary Clinical Trials Communications
·
1
Using Bayesian hierarchical modeling for performance evaluation of clinical trial accrual for a cancer center
2024
·
Xiaosong Shi
, Dinesh Pal Mudaranthakam
, et al.
·
Contemporary Clinical Trials Communications
·
1
The University of Kansas Cancer Center (KUCC), an NCI designated comprehensive cancer center
2023
·
Weijing Sun
, Natalie Streeter
, et al.
·
Molecular Cancer
·
1
PDF
Immunogenicity of Sars-Cov-2 Vaccination in Hematopoietic Stem Cell Transplant and Chimeric Antigen Receptor T-Cell Therapy Recipients
2022
·
Muhammad Umair Mushtaq
, Maggie Nelson
, et al.
·
Transplantation and Cellular Therapy
·
1
A prospective testing SARS-Cov-2/COVID-19 in cancer patients with antitumor treatment
2020
·
Kathan Mehta
, Elizabeth Wulf-Burchfield
, et al.
·
Clinical Cancer Research
·
1
Near–Real-Time Clinical Trial Accrual Dashboard in a National Cancer Institute–Designated Cancer Center: Mixed Methods Implementation Study
2026
·
Sam Pepper
, Isuru Ratnayake
, et al.
·
JMIR Medical Informatics
Evaluating the Impact of Delayed Study Startup on Accrual in Cancer Studies
2025
·
Isuru Ratnayake
, Anh-Tuan Do
, et al.
·
SSRN Electronic Journal
Abstract P4-10-03: Immunogenicity of SARS-CoV-2 vaccination in subjects on active treatment for breast cancer
2022
·
Cory Bivona
, Kevin Li
, et al.
·
Cancer Research
Abstract P13: Prospective voluntary SARS-CoV-2 virus and anti-COVID-19 antibody tests in asymptomatic medical and research staff who work in direct contact with cancer patients: A single center study
2021
·
Weijing Sun
, Andrew K. Godwin
, et al.
·
Clinical Cancer Research
Cancer Therapy and Immunogenicity of COVID Vaccine – CANINE Study
2021
·
Qamar J. Khan
, Cory R. Bivona
, et al.
·
SSRN Electronic Journal
Abstract PO-082: Preliminary analysis of factors associated with COVID-19-related disease severity in cancer patients: University of Kansas Cancer Center experience
2020
·
Anup Kasi
, Elizabeth Wulf-Burchfield
, et al.
·
Clinical Cancer Research
Abstract PO-043: A prospective testing SARS-Cov-2/COVID-19 in cancer patients with antitumor treatment
2020
·
Kathan D. Mehta
, Elizabeth Wulf-Burchfield
, et al.
·
Clinical Cancer Research
Show more works
View as search
Works count:
20
Citation count:
231
H-index:
6
I10-index:
4
Year
Topic
Type